Science


Posts filtered by tags: Fda[x]


 

Pro-Trump Group Files Motion Against FDA to Stop Covid-19 Vaccinations in U.S.

A bizarre fringe group that calls itself “America’s Frontline Doctors” filed a motion in federal court on Monday against the U.S. Department of Health and Human Services, the parent agency of the FDA, to seek an injunction that would halt all vaccinations for covid-19 in the country. And while the lawsuit is unlikely…Read more...
Tags: Science, Medicine, Articles, America, Joe Biden, Medical Research, Alternative Medicine, Fda, Conspiracy Theories, Donald Trump, Trumpism, U S Department of Health and Human Services, Stella Immanuel, Simone Gold, Presidency Of Donald Trump, Covid 19 Vaccine


Johnson & Johnson Recalls Spray Sunscreens Due to Carcinogen Contamination, But Don't Panic

Johnson & Johnson has recalled all lots of five aerosol spray Aveeno and Neutrogena sunscreens after an independent lab found small traces of benzene, a flammable chemical found in cigarette smoke, gasoline, and paint thinner. The lab, Valisure, asked the FDA to recall 78 sun protection products, from a variety of…Read more...
Tags: Science, Fda, Johnson, Don, Johnson Johnson, Neutrogena


Former FDA chief Scott Gottlieb warns of a Delta-driven virus peak at the end of September

FDA commissioner Scott Gottlieb Reuters Former FDA chief Scott Gottlieb warned of a COVID-19 peak at the end of September. The Delta variant would drive up cases over the next few months, he said. "The worst is yet to come," Gottlieb told Squawk Box on Wednesday. See more stories on Insider's business page. Dr. Scott Gottlieb, former head at the Food and Drug Administration, warned Wednesday that a Delta variant-fueled pandemic peak could hit the US in September. Gottlieb told Squawk ...
Tags: Health, Science, News, US, Trends, Healthcare, Delta, Food And Drug Administration, Fda, Pfizer, Vaccine, Squawk Box, Gottlieb, Scott Gottlieb, Centers for Disease Control and Prevention This, Coronavirus


Artificial intelligence could be new blueprint for precision drug discovery

Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
Tags: Science, Fda


Fauci says vaccines should be mandated at the local level but the federal government will not mandate them

Getty/Kevin Dietsch The White House missed its goal of vaccinating 70% of US adults by July 4 amid vaccine hesitancy. Dr. Anthony Fauci said he supported mandates at local institutions like schools and businesses. He also said formal full approval of COVID-19 vaccines in the US might help combat hesitancy. See more stories on Insider's business page. Dr. Anthony Fauci on Sunday said he believed there should be more COVID-19 vaccine mandates at the local level but the federal governmen...
Tags: Science, White House, US, Trends, Cnn, Food And Drug Administration, Dallas, Fda, Vaccine, Anthony Fauci, Jake Tapper, Fauci, Vaccine Hesitancy, Coronavirus, COVID-19, Kelsey Vlamis


Fauci said there should be vaccine mandates at the local level but that the federal government will not mandate them

Getty/Kevin Dietsch The White House missed its goal of vaccinating 70% of US adults by July 4 amid vaccine hesitancy. Fauci said he supports vaccine mandates at the local level, like at schools and businesses. He also said the vaccines are as good as approved, but that formal full approval may help combat hesitancy. See more stories on Insider's business page. Dr. Anthony Fauci said Sunday he believes there should be more COVID-19 vaccine mandates at the local level, though he continu...
Tags: Science, White House, US, Trends, Cnn, Food And Drug Administration, Fda, Vaccine, Anthony Fauci, Jake Tapper, Dallas Texas, Fauci, Vaccine Hesitancy, Coronavirus, COVID-19, Kelsey Vlamis


Booster shots aren't necessary right now, US health agencies say. Pfizer is seeking authorization anyway.

A healthcare worker in the Netherlands receives the Pfizer vaccine on January 6, 2021. Piroschka van de Wouw/Pool via AP Fully vaccinated Americans don't need booster shots right away, US health agencies said on Thursday. Pfizer announced earlier that day that it plans to seek authorization for a booster next month. The spread of the Delta variant has raised concerns about how long vaccine protection lasts. See more stories on Insider's business page. Pharmaceutical companies and d...
Tags: UK, Science, News, Cdc, Israel, US, Trends, Bloomberg, Ap, Netherlands, Delta, Goldman Sachs, Fda, Pfizer, Houston Texas, Immunity


Pfizer Plans to Seek FDA Approval of a Covid-19 Booster in August

Pfizer is looking to fast-track approval for a third booster dose of its covid-19 vaccine and will request emergency authorization from the U.S. Food and Drug Administration in August, Pfizer research head Mikael Dolsten said in a Thursday interview with Bloomberg.Read more...
Tags: Science, Bloomberg, Fda, Pfizer, U S Food and Drug Administration, Mikael Dolsten


FDA Backpedals on Aduhelm Approval, Now Says Only Early Alzheimer's Patients Should Get It

The Food and Drug Administration is altering its recent and controversial approval of a new drug for Alzheimer’s disease. The agency is now recommending that the drug, called Aduhelm and developed by Biogen, only be given to people in the earliest stages of the ultimately fatal neurodegenerative condition. The…Read more...
Tags: Science, Food And Drug Administration, Fda, Biogen


New study estimates America's rapid COVID-19 vaccine rollout saved nearly 300,000 lives

A medical assistant administers a COVID-19 vaccine dose to a woman at a clinic in Los Angeles on March 25, 2021. Mario Tama/Getty Images The US's rapid vaccine rollout helped prevent a spring surge of 4,500 daily COVID-19 deaths, a new study found. Nearly 300,000 lives were saved and 1.25 million hospitalizations prevented by America's vaccine program. Researchers said a "renewed commitment to expanding vaccine access" is necessary to stomp out the virus. See more stories on Insi...
Tags: UK, Science, Cdc, Israel, US, America, Los Angeles, Trends, New York Times, Healthcare, Delta, Vaccination, Fda, Yale School of Public Health, Mario Tama Getty, Moderna


Some experts say J&J vaccine recipients should get an mRNA booster. Here's what we know about mixing shots.

J&J's review process is more compassionate, more conversational, and places a greater emphasis on the employee's future growth. Jakub Porzycki/NurPhoto via Getty Images Some people who got the J&J vaccine are seeking mRNA booster shots. The CDC and FDA don't recommend mixing vaccines, but experts say it can't hurt. Early data on mixing vaccines suggests it could trigger a stronger immune response. See more stories on Insider's business page. As the Delta variant becomes...
Tags: Amazon, UK, Science, Cdc, White House, US, Trends, Spain, Delta, Astrazeneca, Fda, Pfizer, Anthony Fauci, Johnson & Johnson, J J, John Moore


Fauci says he's not going to waste his time with an antibody test, and neither should you

Dr. Anthony Fauci says "you don't have to all individually get a blood test" to know when vaccine protection is waning. Chip Somodevilla/Getty Images / Naveen Sharma/SOPA Images/LightRocket via Getty Images In the weeks after a COVID-19 infection or vaccine, neutralizing antibodies can wane. Other forms of immune protection are still ramping up in the body, standing guard against COVID-19. Fauci says antibody tests are a crude way to assess vaccine protection. Better answers are on the...
Tags: Science, News, California, Washington, Trends, Public Health, Fda, Pfizer, St Louis, Antibodies, Anthony Fauci, New York Yankees, Washington University, Fauci, LabCorp, Memorial Sloan Kettering Cancer Center


Biohackers could drive insulin price down 98 percent

Diabetes is the seventh-leading cause of death in America. About 463 million people (including 34 million Americans) are diabetic.The cost of insulin continues to surge, so the Open Insulin Project is fighting back by replicating medical-grade insulin that can be made at a lab in your neighborhood. The Biohackers Making Insulin 98% Cheaper www.youtube.com The sticker price for a vial of insulin has increased more than 3000 percent over ...
Tags: Science, Biology, America, Spain, Public Health, Innovation, Fda, Pharmaceuticals, University of Toronto, Derek, Socal, Oakland California, Sanofi, American Diabetes Association, Mariana, Pharmaceutical Industry


How much protection you get from one dose of the Pfizer, AstraZeneca, and Moderna vaccines, according to the best available data

Pfizer's COVID-19 vaccine. Getty Millions of people worldwide have had one shot of two-dose COVID-19 vaccines. Pfizer and Moderna's vaccines are likely 80% effective against symptomatic COVID-19 after one dose. A single AstraZeneca shot is probably at least 70% effective at preventing symptomatic COVID-19. See more stories on Insider's business page. More than 179 million Americans and more than 44 million Britons have received their first dose of a two-shot COVID-19 vaccine.Th...
Tags: Health, UK, England, Science, India, Israel, US, Trends, Joe Biden, Data, South Africa, Healthcare, Food And Drug Administration, Brazil, Astrazeneca, Evans


Some experts who had Johnson & Johnson's single-dose vaccine are now getting extra shots of Pfizer or Moderna to try to protect against the Delta variant

A pharmacist at the Hartford Hospital in Hartford, Connecticut, fills a syringe with the Johnson & Johnson COVID-19 vaccine. Joseph Prezioso/Getty Images Some experts who got Johnson & Johnson's one-dose vaccine are topping it up with a dose of Pfizer or Moderna. They did it for extra protection against the fast-spreading Delta coronavirus variant, they said. The FDA and CDC don't recommend getting an extra shot, after a J&J vaccine or otherwise. See more stories on Insider's b...
Tags: Health, UK, Science, News, Cdc, US, Trends, Joe Biden, Healthcare, Delta, Astrazeneca, Fda, Pfizer, Vaccine, Johnson, Anthony Fauci


The Delta variant may be making COVID-19 more common in kids - but severe infections are still rare

Kindergartner Grace Truax, 5, removes her mask before posing for a portrait during "picture day" at Rogers International School on September 23, 2020 in Stamford, Connecticut. John Moore/Getty Images COVID-19 vaccines haven't been authorized for children under age 12 yet. That means kids are at higher risk of contracting Delta, the most transmissible variant to date. But experts are more worried about kids spreading the variant than getting severely ill themselves. See more stories on...
Tags: UK, Science, Kids, News, Children, Scotland, Israel, US, Los Angeles, Trends, Delta, Food And Drug Administration, Fda, Public Health England, Cnbc, Variant


COVID-19 monoclonal antibody therapy can reduce hospitalizations, healthcare system stress

Monoclonal antibodies work well in reducing COVID-19 related emergency department visits and hospitalizations when administered early to high-risk patients, a study by the University of South Florida Health (USF Health) and Tampa General Hospital demonstrates. If used under FDA guidelines, the researchers suggest, this treatment can ease the pandemic's continuing burden on patients and on limited health care resources.
Tags: Science, Fda, Tampa General Hospital, University of South Florida Health USF Health


THE 600-WORD INTERVIEW: The guy who saved Healthcare.gov, and just helped Biden get 150 million Americans vaccinated, explains why we shouldn't just pay people to take the vaccine

Andy Slavitt, the head of President Biden's vaccine rollout and former administrator of the Centers for Medicare and Medicaid Services. Shari L. Gross/Star Tribune/Getty Images Andy Slavitt saved Healthcare.gov, ran Medicare and Medicaid, and headed up Biden's vaccine rollout. He says vaccine-hesitant people don't want to hear from the government. He says we can prevent pandemics if we're less selfish and don't politicize the science. See more stories on Insider's b...
Tags: Politics, Science, Trends, Joe Biden, Healthcare, Medicare, Fda, Vaccines, Biden, Donald Trump, Medicaid, Trump, Centers for Medicare, Medicaid Services, Department of Health and Human Services, Andy Slavitt


Kids are more likely to be vectors for fast-spreading new coronavirus strains like the Delta variant, former FDA chief says

A girl wearing gloves and a face mask before going to the park in Turkey. Not related to this story. Aykut Unlupinar/Anadolu Agency/Getty Images Officials are warning about the spread of the Delta variant, which is currently dominant in the UK. Scott Gottlieb said such contagious variants mean "kids are becoming more likely to be vectors." He predicted that children and schools could "become more of a focal point of spread." See more stories on Insider's business page. The former head ...
Tags: UK, Science, New York City, US, Trends, Turkey, Joe Biden, News UK, Delta, Bill De Blasio, Fda, Cnbc, US Food and Drug Administration, Squawk Box, US Centers for Disease Control and Prevention, Gottlieb


Bizarre Outbreak of Tuberculosis Linked to Donated Bone Grafts, CDC and FDA Officials Say

A contaminated batch of donated bone tissue is the likely source behind a strange outbreak of tuberculosis, according to federal health officials at the Centers for Disease Control and Prevention as well as the Food and Drug Administration. As many as 113 people who went in for spinal repair surgery are thought to…Read more...
Tags: Science, Medicine, Surgery, Food And Drug Administration, Fda, Centers For Disease Control And Prevention, Tuberculosis, Batch, Lot, Antimicrobial resistance, Aziyo Biologics, Clinical Medicine, Medical Specialties, Health Medical Pharma, Mycobacterium Tuberculosis, J I P James


How Pfizer and BioNTech made history with their vaccine

Wondering how Pfizer and partner BioNTech developed a COVID-19 vaccine in record time without compromising safety? Dr Bill Gruber, SVP of Pfizer Vaccine Clinical Research and Development, explains the process from start to finish."I told my team, at first we were inspired by hope and now we're inspired by reality," Dr Gruber said. "If you bring critical science together, talented team members together, government, academia, industry, public health officials—you can achieve what was previously th...
Tags: Health, Science, Technology, Innovation, Fda, Pfizer, Vaccines, Gruber, Food and Drug Administration FDA, EUA, BioNtech, Bill Gruber, Pfizer Vaccine Clinical Research and Development


The US is scrambling to send promised vaccines abroad after the production plant that ruined millions of J&J vaccines may have tainted AstraZeneca shots

A person receives the AstraZeneca vaccine in Bologna, Italy on March 19, 2021. Michele Lapini/Getty Images Emergent BioSolutions in Baltimore ruined at least 15 million Johnson & Johnson vaccines earlier this year. 100 million AstraZeneca and Johnson & Johnson vaccines from the facility are under safety review. The US is scrambling to send vaccines from other manufacturers abroad, The New York Times reported. See more stories on Insider's business page. The US is working to replace ...
Tags: Science, US, Trends, New York Times, The Times, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Biden, Baltimore, Johnson Johnson, Bologna Italy, Moderna, Coronavirus, Sarah Al Arshani


FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

Despite near unanimous objection from its advisory panel, the US Food and Drug Administration (FDA) granted aducanumab approval to treat Alzheimer's disease on June 7, 2021. In a commentary published in Annals of Internal Medicine, a member and former Chair of the advisory panel and an aducanumab site investigator explain why this unprecedented "accelerated approval" is problematic for clinical research and patient care.
Tags: Science, Fda, US Food and Drug Administration FDA


PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions

A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL in detecting and localizing recurrent prostate cancer. Approved by the FDA last month, the radiotracer identified metastatic lesions with high positive predictive values regardless of anatomic region, adding to the evidence that PSMA-targeted radiotracers are the most sensitive and accurate agents for imaging prostate cancer. This study was presented at the ...
Tags: Science, Fda, PSMA


A third member of a prestigious FDA panel has resigned over the approval of a controversial new Alzheimer's drug

Atthapon Raksthaput/Shutterstock A third member of an FDA expert panel has resigned over the agency's accelerated approval of a new Alzheimer's drug. The committee voted against approving the treatment. The FDA isn't required to follow the panel's recommendation but usually does. Aduhelm failed one of its late-stage clinical trials and didn't produce conclusive results in another trial. See more stories on Insider's business page. A third member of a Food and Drug...
Tags: Science, News, US, Trends, Healthcare, Food And Drug Administration, Alzheimer's, Fda, Mayo Clinic, Cnbc, Harvard Medical School, Biogen, Washington University in St Louis, Aaron Kesselheim, Knopman, Kesselheim


Millions of Johnson & Johnson COVID-19 vaccines are set to expire this month, and states are scrambling to use up their stockpiles or send them abroad

Nurse Elizabeth Johnson administers a COVID-19 vaccine to Melissa Mendez in Reading, Pennsylvania. Ben Hasty/MediaNews Group/Reading Eagle/Getty Images States are racing to use up Johnson & Johnson vaccines set to expire later this month, per multiple reports. Ohio, which has 200,000 doses set to expire, says it can't send shots abroad or to other states. Public opinion of the jab has soured after reports of blood clots and manufacturing problems. See more stories on Insider's busi...
Tags: Science, News, Cdc, Oregon, White House, US, Trends, Pennsylvania, Arkansas, Healthcare, Ohio, Philadelphia, Michigan, Fda, Johnson, Baltimore


COVID-19 vaccines could be available for kids as young as 6 months old starting this fall

Dado Ruvic/Reuters Pfizer and Moderna said they could have COVID-19 vaccines for kids as young as 6 months by the fall. Pfizer told The New York Times it would start testing its vaccine in infants in the next few weeks. See more stories on Insider's business page. COVID-19 vaccines could be available for children as young as 6 months in the US by the fall, Pfizer and Moderna told The New York Times on Tuesday.Pfizer announced on Tuesday that it was testing its COVID-19 vaccine in 5- t...
Tags: Science, News, US, Trends, Healthcare, The Times, Food And Drug Administration, Fda, Pfizer, The New York Times, Moderna, Stéphane Bancel, Coronavirus, Bancel, COVID-19, Covid-19 Vaccine


The FDA Just Approved a Controversial Alzheimer's Drug

The Food and Drug Administration on Monday approved the drug aducanumab as a treatment for Alzheimer’s disease, the first ever intended to slow the progression of the incurable dementia. The go-ahead marks a rare case in which the FDA went against the recommendations of the outside panel it solicited for advice, who…Read more...
Tags: Health, Science, Food And Drug Administration, Fda, Life Sciences, Biogen, Pharmaceutical Industry, Drug Discovery, Aducanumab, Clinical Trial, Alzheimers Disease, Health Sciences, FDA Drug, Monoclonal Antibodies, Maria Carrillo, Health Medical Pharma


The FDA just approved the first new Alzheimer's drug in 18 years

Dr. William Burke going over a PET brain scan at Banner Alzheimer's Institute in Phoenix. Biogen's drug was tested against carriers of the APOE gene, which is linked to Alzheimer's, and non-carriers. Matt York/Associated Press The FDA on Monday approved the first new Alzheimer's disease treatment in nearly two decades. Biogen had initially deemed the drug a failure and shut down two late-stage trials. Experts were divided on the drug. One analyst had estimated a 15% chance ...
Tags: Science, News, Trends, Alzheimer's Disease, Healthcare, Food And Drug Administration, Fda, Biotech, Agency, Citi, Alzheimer, William Burke, RBC Capital Markets, Biogen, Eli Lilly, Namenda


FDA approves first new Alzheimer’s drug in almost 20 years

Usefulness of aducanumab is disputed but US approval will trigger push to make it available globallyA controversial new drug for Alzheimer’s disease, the first in nearly 20 years, was approved in the US on Monday, triggering pressure to make it available worldwide in spite of mixed evidence over its efficacy.While doctors, patients and the organisations that support them are desperate for treatments that can slow mental deterioration, the usefulness of the new drug,aducanumab, is disputed by sc...
Tags: Health, Science, Drugs, US, Society, World news, US news, Medical Research, Alzheimer's, Fda, Biogen



Filters
show more filters
May - 2021
MoTuWeThFrSaSu
     12
3456789
10111213141516
17181920212223
24252627282930
31      
June - 2021
MoTuWeThFrSaSu
 123456
78910111213
14151617181920
21222324252627
282930    
July - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728293031